Literature DB >> 19929905

Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management.

Meir Mizrahi1, Tomer Adar, Daniel Shouval, Allan I Bloom, Oren Shibolet.   

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is in widespread use for the decompression of portal pressure. The entity of persistent TIPS infection, also known as 'endotipsitis' is a rare but serious complication of TIPS insertion. The exact definition of 'endotipsitis' is still debated, but involves persistent bacteremia and fever together with either shunt occlusion, or vegetation, or bacteremia in the presence of a patent shunt, when other sources of bacteremia have been ruled out. To date, approximately 40 cases of 'endotipsitis' have been described, with predominance for male and alcoholic hepatitis patients. The clinical course is variable, but fever and chills are a constant feature. Bacteremia, can either occur early (<120 days) or late (>120 days) after stent insertion, with some cases occurring many years after the procedure. Although no predominant bacterial species have been described in 'endotipsitis', staphylococci and other Gram-positive bacteria are more commonly seen in early infection. The diagnosis of 'endotipsitis' is difficult and requires a high index of suspicion. A rigorous imaging work-up to rule out other sources of endovascular infection is usually required including ultrasonography, computed tomography and echocardiography. Because removal of the infected stent is impractical, treatment is empirical and based on a prolonged course of antibiotics. If eligible, some patients may be referred for liver transplantation. The use of prophylactic antibiotics during the initial TIPS procedure is controversial, and despite the lack of evidence, prophylaxis is the common practice. The aim of this review was to describe the definition, clinical course, diagnosis, pathogenesis, microbiology, treatment and outcome of endotipsitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929905     DOI: 10.1111/j.1478-3231.2009.02158.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

1.  Bacteremia and "Endotipsitis" following transjugular intrahepatic portosystemic shunting.

Authors:  Meir Mizrahi; Lilach Roemi; Daniel Shouval; Tomer Adar; Maya Korem; Alon Moses; Alan Bloom; Oren Shibolet
Journal:  World J Hepatol       Date:  2011-05-27

Review 2.  Transjugular intrahepatic portosystemic shunt complications: prevention and management.

Authors:  Paul V Suhocki; Matthew P Lungren; Baljendra Kapoor; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 3.  Transhepatic Revision of Occluded Transjugular Intrahepatic Portosystemic Shunt Complicated by Endotipsitis.

Authors:  Anne Williams Darrow; Ron C Gaba; R Peter Lokken
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

Review 4.  Fungal endotipsitis: A case report and literature review.

Authors:  Thomas R McCarty; Jordan Sack; Bakhtiar Syed; Roger Kim; Basile Njei
Journal:  J Dig Dis       Date:  2017-04       Impact factor: 2.325

5.  High-dose daptomycin monotherapy cures Staphylococcus epidermidis 'endotipsitis' after failure of conventional therapy.

Authors:  Julia Marie Colston; Matthew Scarborough; Jane Collier; Ian C J W Bowler
Journal:  BMJ Case Rep       Date:  2013-04-16

6.  New Case of Endotipsitis: Urgent Need for Clinical Practice Guidelines.

Authors:  Alberto Garcia-Zamalloa; Jorge Taboada Gomez; Agustín Castiella Egusquiza
Journal:  Eurasian J Med       Date:  2017-10

7.  Endotipsitis: A case report with a literature review on an emerging prosthetic related infection.

Authors:  Annalan Md Navaratnam; Matthew Grant; David B Banach
Journal:  World J Hepatol       Date:  2015-04-08

Review 8.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

9.  Endotipsitis: An Underdiagnosed Complication of Transjugular Intrahepatic Portosystemic Shunts.

Authors:  Vettakkara K M Niyas; Vishakh C Keri; Prabhat Kumar
Journal:  J Clin Exp Hepatol       Date:  2021-03-05

10.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.